药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Econazole
Vesencumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Vesencumab.
Econazole
Tomaralimab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Tomaralimab.
Econazole
Ladiratuzumab vedotin
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Ladiratuzumab vedotin.
Econazole
GMA-161
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with GMA-161.
Econazole
Pidilizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Pidilizumab.
Econazole
Istiratumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Istiratumab.
Econazole
Evinacumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Evinacumab.
Econazole
Sofituzumab vedotin
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Sofituzumab vedotin.
Econazole
Valanafusp alfa
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Valanafusp alfa.
Econazole
Gedivumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Gedivumab.
Econazole
Nemolizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Nemolizumab.
Econazole
Mitazalimab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Mitazalimab.
Econazole
Suvratoxumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Suvratoxumab.
Econazole
Asunercept
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Asunercept.
Econazole
Ponezumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Ponezumab.
Econazole
Zolbetuximab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Zolbetuximab.
Econazole
Utomilumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Utomilumab.
Econazole
Telisotuzumab vedotin
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Telisotuzumab vedotin.
Econazole
Tigatuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Tigatuzumab.
Econazole
Tezepelumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Tezepelumab.